Zynerba Pharmaceuticals CEO Armando Anido's 2022 pay slips 15% to $1.9M
Zynerba Pharmaceuticals reports 2022 executive compensation
By ExecPay News
Published: April 21, 2023
Zynerba Pharmaceuticals reported fiscal year 2022 executive compensation information on April 21, 2023.
In 2022, three executives at Zynerba Pharmaceuticals received on average a compensation package of $1.5M, a 10% decrease compared to previous year.
Average pay of disclosed executives at Zynerba Pharmaceuticals
Armando Anido, Chief Executive Officer, received $1.9M in total, which decreased by 15% compared to 2021. 34% of Anido's compensation, or $633K, was in salary. Anido also received $284K in non-equity incentive plan, $368K in option awards, $578K in stock awards, as well as $17K in other compensation.
Terri B. Sebree, President, received a compensation package of $1.4M, which decreased by 14% compared to previous year. 35% of the compensation package, or $486K, was in salary.
James E. Fickenscher, Chief Financial Officer, earned $1.3M in 2022, a 5% increase compared to previous year.
Related executives
You may also like
Source: SEC filing on April 21, 2023.